Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00091507 · ClinicalTrials.gov registry record · Phase 3
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
A Phase 3 study of Cardiovascular Diseases and Heart Diseases, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 911
- Enrollment target
- 13
- Study locations
NCT00091507: Completed Phase 3 study of Cardiovascular Diseases and Heart Diseases, sponsored by Tufts Medical Center.
NCT00091507 is a Phase 3 study of Cardiovascular Diseases and Heart Diseases that has completed, run by Tufts Medical Center. The registered enrollment target is 911 participants, below the 26,971-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The trial reports 13 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00091507, a Phase 3 study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 911 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to test the impact of pharmacological myocardial metabolic support, in the form of intravenous (IV) glucose, insulin and potassium (GIK), for the treatment of patients with threatened or established acute myocardial infarction (AMI).
Primary Outcome
Outcome for all participants during the first 24 hours of hospitalization; evidence of myocardial infarction is determined by ECG and biomarker results.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG GIK
Study Locations (13)
Massachusetts
- Brockton Site - Brockton
- Concord Site - Concord
Texas
- Dallas Site - Dallas
- El Paso Site - El Paso
Alaska
- Anchorage Site - Anchorage
Connecticut
- New Haven Site - New Haven
Georgia
- Macon Site - Macon
Minnesota
- St. Paul Site - Saint Paul
New Mexico
- Albuquerque Site - Albuquerque
Pennsylvania
- Hershey Site - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 911 participants |
| Start Date | 2006-11 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
What the finished NCT00091507 record still lists
NCT00091507 is an interventional study that assigns participants to a tested intervention. The registered 911 participants enrollment target is mid-sized for trials with a published cap, below the 26,971-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower).
The record links to 6 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00091507 lists 13 locations in 11 states (Massachusetts, Texas, Alaska).
Frequently Asked Questions
What is clinical trial NCT00091507 about?
NCT00091507 is a clinical study titled "IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.". The purpose of this study is to test the impact of pharmacological myocardial metabolic support, in the form of intravenous (IV) glucose, insulin and potassium (GIK), for the treatment of patients with threatened or established acute myocardial infarction (AMI).
What is the current status of trial NCT00091507?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 911 participants. The study started on 2006-11. Estimated completion is 2012-08.
What conditions does trial NCT00091507 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Myocardial Infarction, Heart Failure, Congestive, Coronary Disease.
What interventions are being tested in trial NCT00091507?
The interventions under investigation include: Placebo (DRUG), GIK (DRUG).
Who is sponsoring clinical trial NCT00091507?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00091507 being conducted?
This trial has 13 study locations across Alaska, Connecticut, Georgia, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00091507's enrollment target sits among peer trials
911 60th of 300 higher than 241 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RECRUITING · Phase 3
-
Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
ACTIVE NOT RECRUITING · Phase 3
-
Comparison of Hematocrit Levels in Infant Heart Surgery
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT05739955 · 918 participants · NA
Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia